InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,344.39
(
0.00%
)
US TECH 100
18,188.00
(
0.74%
)
Dow Jones
39,357.01
(
-0.36%
)
Brent Oil
81.58
(
-0.04%
)
Bitcoin
59,103.90
(
-0.42%
)

Replies to post #119448 on Biotech Values

Replies to #119448 on Biotech Values
icon url

DewDiligence

05/05/11 9:02 PM

#119449 RE: jq1234 #119448

That plus the longstanding safety profile (#msg-62332894) ensure that US Copaxone sales will never fall off a cliff, no matter how many of the oral MS drugs end up being approved in the next few years.
icon url

DewDiligence

09/26/12 4:54 PM

#149438 RE: jq1234 #119448

Paper in Science Translational Medicine broaches MS biomarkers suitable for treatment decisions:

http://www.bloomberg.com/news/2012-09-26/dual-multiple-sclerosis-finding-may-change-therapy.html